Umoja

is a Washington-based biotechnology company that develops and commercializes CAR T-cell therapies for the treatment of cancer...
Read more
Umoja Co-Founder & CEO: Andrew M. Scharenberg

Co-Founder & CEO

Andrew M. Scharenberg

CEO Approval Rating

90/100

Est. Annual Revenue
$100K-5.0M
Agree?
Est. Employees
25-100
Agree?
Funding
$363M

Umoja Competitors

1Tmunity
2PACT Pharma
3Geneos Therapeutics
4NexImmune
5TScan
6Juno Therapeutics
7Aura
8Perthera
9bluebird bio
10Jounce

Trending Companies